
Request appointment
300 East 66th StreetFloors 1 - 4New York, NY 10065
Overview of Dr. Modi
Dr. Shanu Modi is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Alberta and has been in practice 31 years. Dr. Modi accepts several types of health insurance, listed below. She is one of 537 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 100 publications and over 500 citings.
Education & Training
University of AlbertaClass of 1995
Certifications & Licensure
FL State Medical License 2022 - Present
NJ State Medical License 2020 - 2027
NY State Medical License 2004 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016
Clinical Trials
- A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
- Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer
- The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies Start of enrollment: 2011 Jul 06
Publications & Presentations
PubMed
- ERBB2 Activating Mutations Promote Enhanced Internalization and Activity of Trastuzumab Deruxtecan in HER2-non-amplified Metastatic Breast Cancer.Nicholas Mai, Sharanya Nag, Bo Liu, Wanyi Chen, Atif Ali Hashmi
Clinical Cancer Research. 2026-09-09 - 1 citationsPathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/...Nadine Tung, Fengmin Zhao, Angela DeMichele, Aleix Prat, Eric P Winer
Journal of Clinical Oncology. 2026-08-20 - Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label...Shanu Modi, Rashmi K Murthy, A Jo Chien, Nancy U Lin, Nicholas P McAndrew
Clinical Breast Cancer. 2026-08-01
Press Mentions
Daily Takeaways from the AACR Annual Meeting 2025: Tuesday, April 29April 29th, 2025
T-dXd Benefits Persist for HER2-Low Breast CancerNovember 8th, 2023
These Major Breakthroughs of 2022 Will Affect Health for Years to ComeDecember 25th, 2022
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: